Dietary vitamin E and Parkinson's disease: something to chew on

A double-blind, controlled trial of circadian effective light therapy in patients with Parkinson's disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025

CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial.

EClinicalMedicine·2024

Continuous Levodopa Delivery with an Intraoral Micropump System: An Open-Label Pharmacokinetics and Clinical Study.

Movement disorders : official journal of the Movement Disorder Society·2024

Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.

The Lancet. Neurology·2024

A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.

Journal of Parkinson's disease·2024

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

The Lancet. Neurology·2023

Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Neurology·2026

Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.

The Lancet. Neurology·2026

Advances in chronic subdural haematoma management: beyond the burr hole.

The Lancet. Neurology·2026

Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study.

The Lancet. Neurology·2026

Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis.

The Lancet. Neurology·2026

Safety and efficacy of guanabenz in early-childhood onset vanishing white matter: primary analysis of a single-arm, phase 1/2 trial.

The Lancet. Neurology·2026

Online-Sourced Retatrutide Complicating Impending Diabetic Ketoacidosis in a Patient With Type 1 Diabetes and Concurrent Shigella Gastroenteritis.

Cureus·2026

Comparison of the effectiveness of oral lactase enzyme and lactose-free formula in the management of secondary lactose intolerance in persistent and severe persistent diarrhea.

Pakistan journal of medical sciences·2026

Vitamin C intake is a novel potential therapeutic approach in the secretion of adiponectin and in the treatment of abdominal obesity.

Caspian journal of internal medicine·2026

Short-term BMI changes associated with self-selected weight-control dietary patterns among Chinese office-based adults using a digital health platform: An exploratory real-world observational study.

Digital health·2026

Intrapancreatic fat deposition shows distinct regional and compartmental associations with obesity and diabetes.

iScience·2026

The Weight of Responsibilities: Time in Responsibilities and in Food Preparation.

Current developments in nutrition·2026

Related Experiment Videos

Dietary vitamin E and Parkinson's disease: something to chew on

Related Concept Videos

A double-blind, controlled trial of circadian effective light therapy in patients with Parkinson's disease.

CVN424, a GPR6 inverse agonist, for Parkinson's disease and motor fluctuations: a double-blind, randomized, phase 2 trial.

Continuous Levodopa Delivery with an Intraoral Micropump System: An Open-Label Pharmacokinetics and Clinical Study.

Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.

A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson's Disease.

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.

Advances in chronic subdural haematoma management: beyond the burr hole.

Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study.

Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis.

Safety and efficacy of guanabenz in early-childhood onset vanishing white matter: primary analysis of a single-arm, phase 1/2 trial.

Online-Sourced Retatrutide Complicating Impending Diabetic Ketoacidosis in a Patient With Type 1 Diabetes and Concurrent Shigella Gastroenteritis.

Comparison of the effectiveness of oral lactase enzyme and lactose-free formula in the management of secondary lactose intolerance in persistent and severe persistent diarrhea.

Vitamin C intake is a novel potential therapeutic approach in the secretion of adiponectin and in the treatment of abdominal obesity.

Short-term BMI changes associated with self-selected weight-control dietary patterns among Chinese office-based adults using a digital health platform: An exploratory real-world observational study.

Intrapancreatic fat deposition shows distinct regional and compartmental associations with obesity and diabetes.

The Weight of Responsibilities: Time in Responsibilities and in Food Preparation.

Related Experiment Videos

Dietary vitamin E and Parkinson's disease: something to chew on

Related Concept Videos

Related Articles